Interleukin-36β exacerbates DSS-induce acute colitis via inhibiting Foxp3+ regulatory T cell response and increasing Th2 cell response

International Immunopharmacology(2022)

Cited 8|Views13
No score
Abstract
•IL-36β expression was elevated in the colon of mice with DSS-induced colitis.•rIL-36β administration aggravates DSS-induced colitis in mice.•rIL-36β treatment promotes Th2 cell response in mice with DSS-induced colitis.•rIL-36β treatment suppresses Foxp3+ Treg response in mice with DSS-induced colitis.
More
Translated text
Key words
Interleukin-36β,Dextran sulfate sodium,Colitis,Th2 cell,Foxp3+ regulatory T cell
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined